Clinical Trial Detail

NCT ID NCT03853707
Title Ipatasertib and Carboplatin With or Without Paclitaxel in Treating Patients With Metastatic Triple Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors City of Hope Medical Center
Indications

triple-receptor negative breast cancer

Therapies

Carboplatin + Ipatasertib + Paclitaxel

Carboplatin + Ipatasertib

Age Groups: senior adult

No variant requirements are available.